View Article

Abstract

Surgical Site Infections (SSIs) are among the most frequent postoperative complications, especially in low-resource settings, leading to delayed recovery, prolonged hospitalization, and increased healthcare costs. This prospective observational study aimed to evaluate the incidence, microbial spectrum, risk factors, and antibiotic susceptibility patterns of SSIs among general surgery patients in a tertiary care hospital in South India. The study was conducted over a six-month period (April to September 2024) in the Department of General Surgery, Government Medical College Hospital, Nagapattinam. A total of 150 postoperative patients aged 18 to 65 years were included. Clinical data were recorded, and wound swab samples from suspected SSI cases were collected and analyzed using standard microbiological methods. Antimicrobial susceptibility testing was performed in accordance with CLSI guidelines. Out of 150 patients, 70 developed SSIs, resulting in an incidence rate of 46.6%. Males were more commonly affected. The most frequently isolated pathogens included Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae. Gram-negative isolates exhibited high resistance to third-generation cephalosporins, whereas meropenem and piperacillin-tazobactam showed better efficacy. Methicillin-resistant Staphylococcus aureus (MRSA) isolates were sensitive to vancomycin and linezolid. Diabetes, emergency procedures, and prolonged preoperative hospitalization were notable risk factors. This study highlights the substantial burden of SSIs and the growing challenge of antimicrobial resistance. Routine surveillance, individualized antibiotic therapy, and optimization of perioperative practices are essential for improving surgical outcomes.

Keywords

Surgical Site Infections, Risk Factors, Antimicrobial Resistance, Prospective Study, General Surgery, South India

Introduction

Surgical Site Infections (SSIs) are among the most frequently encountered healthcare-associated infections (HAIs), especially in low- and middle-income countries. The World Health Organization (WHO) reports that SSIs affect nearly one-third of surgical patients in developing regions, resulting in considerable clinical and economic burden (1). The term "surgical site infection" was standardized by the Centers for Disease Control and Prevention (CDC) in 1992, encompassing infections occurring within 30 days post-surgery or within one year if an implant is involved (2).

In India, the incidence of SSIs has been reported to range from 4% to 30%, depending on hospital setting, patient comorbidities, and infection control practices (3). Factors such as diabetes, prolonged hospitalization, emergency procedures, and contaminated wounds significantly increase SSI risk (4). The rising prevalence of antimicrobial resistance further complicates treatment, particularly due to multidrug-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacilli (5,6).

Previous studies in India have consistently shown that Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae are the predominant organisms isolated from SSIs, with variable resistance profiles to commonly prescribed antibiotics (7,8). These findings highlight the need for localized microbiological surveillance to guide empirical therapy and antibiotic stewardship efforts.

Objective Of the Study:

This prospective study was undertaken to assess the incidence of SSIs, identify associated risk factors, characterize the microbial profile, and evaluate the antimicrobial susceptibility patterns among general surgery patients at Government Medical College Hospital, Nagapattinam.

MATERIALS AND METHODS:

This prospective observational study was conducted in the Department of General Surgery, Government Medical College Hospital, Nagapattinam, Tamil Nadu, over a period of six months, from April 2024 to September 2024. The study received approval from the Institutional Human Ethics Committee with proposal number GMCN/IEC/2024/1/38 prior to commencement. A total of 150 post-operative patients aged between 18 and 65 years, admitted for various surgical procedures, were enrolled based on inclusion and exclusion criteria.

Inclusion Criteria:

  • Patients aged between 18 and 65 years.
  • Patients of either gender who developed SSIs following surgical procedures.
  • Patients who provided informed consent

Exclusion Criteria

  • Patients whose surgical procedures were aborted or significantly altered.
  • Patients with chronic non-surgical wounds or ulcers
  • Patients on long-term antimicrobial therapy prior to surgery
  • Patients with pre-existing infections or immuno-compromised states

Study Design and Data Collection

Eligible patients were prospectively evaluated from the time of admission through discharge. A structured case record form was used to capture demographic data (age, gender, BMI), social habits (smoking, alcohol), comorbidities (diabetes, hypertension), wound classification, prophylactic antibiotic use, type and duration of surgery, and hospital stay. Patients were then stratified into two groups: those who developed SSIs and those who did not.

Aseptic wound swab or pus samples were obtained from patients with suspected SSIs and promptly sent to the microbiology laboratory for analysis. Samples were cultured on blood agar and MacConkey agar and incubated aerobically at 37°C for 24 to 48 hours. Organisms were identified using standard biochemical tests. Antimicrobial susceptibility testing was performed by the Kirby-Bauer disc diffusion method on Mueller-Hinton agar, and results were interpreted as per Clinical and Laboratory Standards Institute (CLSI) 2023 guidelines.

Multidrug-resistant organisms such as MRSA and ESBL producers were specifically identified and documented.

Statistical Analysis

All data were entered and managed using Microsoft Excel 2013. Descriptive statistics, including frequency and percentage, were used to summarize demographic characteristics, risk factors, and antimicrobial susceptibility patterns. Graphical representations such as bar diagrams and pie charts were used where appropriate.

RESULTS:

1. Overall Incidence of Surgical Site Infections:

Out of the 150 cases collected during the study period, 70 patients were found to have surgical site infections. The overall incidence of surgical site infections during the study period is 46.6%. This is illustrated in Table 1 and Figure 1.

Table 1: Incidence of Surgical Site Infections

Event

No. of patients

Percentage

SSI

70

46.6%

No SSI

80

53.4%

Total

150

 

2. Age And Gender Distribution:

Out of the 150 patients, 91 (60%) were male and 59 (40%) were female. SSIs occurred more frequently in males (63%) than in females (37%). This is illustrated in Table 2 and Figure 2.

The highest incidence of SSIs was observed in the 50–60 years age group (43%), followed by 40–50 years (31%) and 30–40 years (17%). This is illustrated in Table 3 and Figure 3.

Figure 1 Incidence of Surgical Site Infections

Table 2 Gender Distribution of Patients

Patient Gender

Total no. of patients n= 150

SSI Event n= 70

Male

91 (60%)

44(63%)

Female

59 (40%)

26 (37%)

Figure 2 Gender Distribution of Patients

Table 3 Age Distribution of Patients

Patient Age

Total no. of patients(%) n= 150

SSI Event(%) n= 70

20-30

18 (12%)

6 (9%)

30-40

28 (19%)

12 (17%)

40-50

42 (28%)

22 (31%)

50-60

62 (41%)

30 (43%)

Figure 3  Age Distribution of Patients

3. Risk Factor Analysis

  1. Social Habits

Out of the 150 patients studied, 85 (57%) patients were found to be alcoholic, and 65 (43%) patients were found to be smokers. In the 70 patients identified with surgical site infections, 50(71%) patients were alcoholic, and 20(29%) patients were found to be smokers.

Higher predominance of surgical site infection was among alcohol consuming patients than smokers. This is shown in Table 4 and Figure 4.

Table 4 Social Habit Distribution of Patients

Social Habit

Total no. of patients(%)

n= 150

SSI

Event(%) n= 70

Alcohol

85 (57%)

50 (71%)

Smoking

65(43%)

20 (29%)

Figure 4 Social Habit Distribution of Patients

  1. Comorbidities

Out of the 150 patients, 95(63%) patients had Diabetes, and 55(37%) patients had hypertension. Among the 70 surgical site infected patients, 46(66%) were found to be Diabetic and 24(34%) were found to have Hypertension. The rate of surgical site infections was high among Diabetic patients. This is illustrated in Table 5 and Figure 5.

Table 5 Comorbidity Distribution of Patients

Comorbidity

Total no. of patients(%)

n= 150

SSI

Event(%)

n= 70

Diabetes Mellitus

95 (63%)

46 (66%)

Hypertension

55 ( 37%)

24 (34%)

Figure 5 Comorbidity Distribution of Patients

  1. Type of Surgery

Out of 150 patients, 58 have undergone Elective surgery and 92 have undergone Emergency surgery. Among 70 surgical site infected patients, 15 (21%) patients underwent elective surgery, and 55 (79%) patients underwent emergency surgery.

The rate of surgical site infection was higher in emergency surgeries (79%) when compared to elective surgeries. This is illustrated in Table 6 and Figure 6.

Table 6 Type of Surgery Distribution in Patients

Surgery type

Total no. of

Patients(%)

n= 150

SSI Event(%)

n= 70

Emergency

92 (61%)

55 (79%)

Elective

58 (39%)

15 (21%)

Figure 6 Type of Surgery Distribution of Patients

4. Prophylactic antibiotics used for the prevention of surgical site infections.

Several antibiotic agents are given before a surgical procedure to prevent the occurrence of surgical site infections. The most commonly prescribed antibiotics are mentioned in the table and figure below.

The most commonly prescribed antibiotics for surgical prophylaxis of infection include.

  • Metronidazole
  • Cefotaxime
  • Ceftriaxone
  • Piperacillin Tazobactam
  • Amikacin
  • Cefoperazone Sulbactam

This is illustrated in Table 7 and Figure 7.

Table 7 Usage of Prophylactic Antibiotics

Antibiotics

Total no. of patients n= 150

Metronidazole

135 (90%)

Cefotaxime

80 (54 %)

Ceftriaxone

76 (51%)

Piperacillin Tazobactam

56 (37 %)

Amikacin

40 (27%)

Cefoperazone Sulbactam

35 ( 23%)

Ciprofloxacin

33 (22%)

Gentamicin

11 ( 20%)

Doxycycline

10 (7%)

Figure 7 Usage of Prophylactic Antibiotics

5. Bacteriology of Surgical Site Infections:

In the 70 patients detected with surgical site infections, the organisms responsible for causing surgical site infections are;

  • GRAM NEGATIVE: 79%
  • GRAM POSITIVE:  21%.

This is illustrated in Table 8 and Figure 8.

Table 8 Types of Bacteria Causing Surgical Site Infections

Type of Microbe

No. of Microbes (%)

Gram Negative

55 (79%)

Gram Positive

15 (21%)

  1. Gram Positive Bacteria

Out of the 15 Gram positive bacteria isolated, Streptococcus aureus is the only strain isolated. A large proportion of Methicillin Resistant Staphylococcus aureus have been detected. The distribution is illustrated in Table 9.

Streptococcus aureus accounts for 20% of all the infections. Methicillin Resistant Staphylococcus aureus accounts for 80% of all the infections.

Table 9 Distribution of Gram-Positive Bacteria

Gram Positive n=15

No of microbes

Percentage(%)

Methicillin Resistant Staphylococcus aureus

12

80%

Staphylococcus aureus

3

20%

  1. Gram Negative Bacteria

Out of the 55 Gram negative bacteria detected Escherichia coli(E coli) is the most predominant strain accounting for 29% of all the infections. This is followed by Klebsiella pneumonia accounting for 21% of all the infections and Pseudomonas aeruginosa accounting for 18% of all the infections. The distribution of various Gram-negative bacteria is illustrated in the below table and figure.

Table 10 Distribution of Gram-Negative Bacteria

Gram Negative

n= 55

No. of Microbes

Percentage

Escherichia coli

16

29%

Klebsiella pneumonia

12

21%

Pseudomonas aeruginosa

10

18%

Proteus mirabilis

5

9%

Proteus vulgaris

4

7%

Klebsiella oxytoca

4

7%

Citrobacter species

4

7%

Figure 8 Distribution of Gram-Negative Bacteria

4. Antibiotic Sensitivity of Gram-Positive Bacteria

Most of the gram-positive bacteria showed a maximum of 100% sensitivity to doxycycline followed by 67% sensitivity to Cotrimoxazole, 33% sensitivity to Clindamycin and Linezolid. 17% sensitivity was observed for Azithromycin and Erythromycin.

Staphylococcus aureus showed high sensitivity to Doxycycline (100%) and Cotrimoxazole (67%). Methicillin Resistant Staphylococcus aureus showed high sensitivity to Doxycycline (75%) and Linezolid (33%).

Table 11 Antibiotic Sensitivity of Gram-Positive Bacteria

Antibiotics

Methicillin Resistant

Staphylococcus

aureus n= 12

Staphylococcus

aureus

n= 3

Doxycycline

9 (75%)

3 (100%)

Cotrimoxazole

3 (25%)

2 (67%)

Azithromycin

2 (17%)

0 (0%)

Linezolid

4 (33%)

0 (0%)

Erythromycin

2(17%)

0 (0%)

Clindamycin

2 (17%)

1 (33%)

5.Antibiotic Sensitivity of Gram-Negative Bacteria

The Gram-negative bacteria were highly sensitive to ciprofloxacin (66.6%) followed by Gentamicin (56.25%), Piperacillin Tazobactam (55.5%)

The most commonly isolated Gram-negative bacteria E.coli showed high sensitivity to Ciprofloxacin (56.25%) followed by Piperacillin Tazobactam and Gentamicin (50%)

Klebsiella spp showed high sensitivity to Gentamicin (56.25%) followed by Ciprofloxacin and Piperacillin Tazobactam (31.25%)

Pseudomonas spp showed high sensitivity to Ciprofloxacin and Gentamicin (40%).

Proteus spp showed high sensitivity to Ciprofloxacin (66.6%) followed by Piperacillin Tazobactam (55.5%) and Cotrimoxazole (22.2%)

Citrobacter spp showed high sensitivity to Ciprofloxacin(75%) followed by Piperacillin Tazobactam and Gentamicin (50%).

Table 12 Antibiotic Sensitivity of Gram-Negative Bacteria

Antibiotic

Klebsiella spp

n=16

E coli

n= 16

Pseudomonas Spp

n= 10

Proteus spp

n= 9

Citrobacter spp

n= 4

Cefoperazone

sulbactam

1 (6.2%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Ciprofloxacin

5(31.25%)

9 (56.25%)

4 (40%)

6 (66.6%)

3 (75%)

Piperacillin

Tazobactam

5 (31.25%)

8 (50%)

5 (50%)

5 (55.5%)

2 (50%)

Amikacin

3 (18.75%)

2 (12.5%)

0 (0%)

1 (11.11%)

0 (0%)

Cotrimoxazole

3 (18.75%)

3 (18.75%)

0 (0%)

2 (22.2%)

0 (0%)

Gentamicin

9 (56.25%)

8 (50%)

4 (40%)

1(11.1%)

2 (50%)

Meropenem

0 (0%)

4(25%)

0 (0%)

0 (0%)

0 (0%)

Cefotaxime

3 (18.75%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

DISCUSSION

Surgical Site Infections (SSIs) continue to be a significant cause of postoperative morbidity, especially in resource-limited healthcare settings. In the present study conducted over a six-month period in a tertiary care hospital in South India, the incidence of SSIs was found to be 46.6%. This is consistent with previous reports by Patel et al. (40.8%) and Bastola et al. (48.6%), highlighting a similar burden in comparable tertiary care settings [6,9].

Gender-wise distribution revealed a higher incidence of SSIs among males (63%), which aligns with the observations of Naz et al. (60%) and Budhani et al. (56%) [10,11]. The greater vulnerability in males could be attributed to occupational exposure, higher rates of smoking and alcohol consumption, and delayed healthcare-seeking behavior.

Age-related analysis showed that individuals in the 50–60-year age group were most affected, in agreement with findings from Saxena et al., who reported increased SSI risk in older adults due to declining immunity and higher prevalence of comorbidities [12].

Comorbidity analysis indicated that diabetes mellitus (66%) was the most significant risk factor associated with SSIs in this study, echoing the conclusions of Khairy et al. and Giridhar et al., who also identified diabetes as a major contributor to postoperative infections [13,14]. Similarly, 71% of SSI cases were associated with alcohol use, consistent with the study by Reeja Jiji et al., which found alcohol consumption to be a notable behavioral risk factor for poor wound healing [15].

Emergency surgeries accounted for 79% of all SSI cases in the present study. This finding is supported by Thummar et al., who noted a significantly higher incidence of SSIs following emergency procedures, possibly due to inadequate preoperative preparation and compromised aseptic techniques [16].

Antibiotic prophylaxis patterns in this study showed metronidazole as the most commonly administered drug, followed by ceftriaxone. This trend contrasts with the findings of Bastola et al., where ceftriaxone was the most frequently prescribed agent [9]. Such variations could be due to differences in local antibiotic policies or surgeon preference.

Microbiologically, the predominance of Gram-negative organisms (79%) over Gram-positive organisms (21%) aligns with the findings of Chaudhari et al., who reported a Gram-negative dominance of 84.6% in SSI cases [18]. Among Gram-negative isolates, Escherichia coli (29%) was the most frequently identified pathogen, followed by Klebsiella pneumoniae (21%) and Pseudomonas aeruginosa (18%). These results corroborate the microbial patterns reported by Reeja Jiji et al. [15].

Among Gram-positive organisms, Staphylococcus aureus was the most common isolate (20%), with 12 of those identified as Methicillin-resistant S. aureus (MRSA). This is partially consistent with Bastola et al., who documented 14 MRSA isolates among their patient cohort [9].

In terms of antimicrobial susceptibility, ciprofloxacin exhibited the highest efficacy among Gram-negative isolates (66.6%), followed by gentamicin (56.25%) and piperacillin-tazobactam (55.5%). These findings align closely with those of Verma et al., who also observed ciprofloxacin to be the most effective agent (75.76%) [19].

Interestingly, all Gram-positive isolates in the current study showed 100% sensitivity to doxycycline, while sensitivity to linezolid was only 33%. This contrasts with Misbah Najam et al., who reported universal sensitivity of Gram-positive isolates to vancomycin and linezolid [20]. Such discrepancies may reflect local antibiotic resistance trends and warrant further investigation.

Overall, this study reinforces the critical need for ongoing microbiological surveillance and institutional antibiotic stewardship programs to combat rising resistance and optimize patient outcomes. Risk stratification based on comorbidities, age, and surgical factors can further help in SSI prevention.

CONCLUSION

This prospective study highlights a notably high incidence of surgical site infections in a general surgery ward of a tertiary care hospital in South India, with a clear predominance of Gram-negative bacterial isolates. Risk factors such as diabetes mellitus, alcohol consumption, emergency surgeries, and prolonged hospital stays were found to be significantly associated with SSI development. The widespread resistance to commonly used antibiotics—particularly among Gram-negative pathogens—underscores the urgent need for localized antibiotic stewardship and robust infection control practices.

Regular microbiological surveillance, early identification of high-risk patients, and strict adherence to aseptic surgical techniques are crucial in reducing SSI-related morbidity. Empirical antibiotic therapy should be guided by regional antibiograms to ensure optimal patient outcomes and to mitigate the growing threat of antimicrobial resistance.

ACKNOWLEDGMENT

The authors would like to express their sincere gratitude to the Department of General Surgery and the Department of Microbiology, Government Medical College Hospital, Nagapattinam, for their invaluable support and cooperation throughout the course of the study. The authors also extend their  thanks to the patients who consented to participate. Special appreciation is extended to Dr.M.Arhoul Rennies, our project guide, for his continued support throughout the study.

CONFLICT OF INTEREST

The authors declare that there is no conflict of interest related to the publication of this manuscript.

REFERENCES

  1. World Health Organization. Global guidelines for the prevention of surgical site infection. Geneva: WHO; 2016.
  2. Centers for Disease Control and Prevention (CDC). National Nosocomial Infections Surveillance (NNIS) System Report, 1992.
  3. Anvikar AR, Deshmukh AB, Karyakarte RP, et al. A one year prospective study of 3,280 surgical wounds. Indian J Med Microbiol. 1999;17(3):129–132.
  4. National Healthcare Safety Network (NHSN) Risk Index. CDC, 2021.
  5. Shanmugam G, Venkatesh B, Perumal M. Bacteriological profile of surgical site infections and their antibiogram in a teaching hospital. J Clin Diagn Res. 2012;6(6):1040–1044.
  6. Patel LP, Panchal SJ. Antibiotic susceptibility pattern of organisms causing surgical site infection at a tertiary care hospital in Gujarat, India. Int J Basic Clin Pharmacol. 2013;2(3): 295–298.
  7. Gomathi S, Srirangaraj S. A study of surgical site infections in a teaching hospital. Int J Curr Microbiol App Sci. 2015;4(10):784–790.
  8. Vyas K, Jain S, Dave M. Surgical site infections and antimicrobial resistance pattern: A study from Western Rajasthan. Int J Res Med Sci. 2016;4(7):2937–2942.
  9. Bastola R, Parajuli P, Neupane A, Paudel A. Surgical site infections: Distribution studies of sample, outcome and antimicrobial susceptibility testing. J Med Microb Diagn. 2017;6:252. doi:10.4172/2161-0703.1000252
  10. Naz R, Hussain SM, Ain Qul. Bacteriological profile of surgical site infections and their antibiotic susceptibility pattern. SSR Inst Int J Life Sci. 2019;5(2):2224–2229.
  11. Budhani D, Kumar S, Sayal P, Singh S. Bacteriological profile and antibiogram of surgical site infection/post-operative wound infection. Int J Med Res Rev. 2016;4(11):1994–1999.
  12. Saxena A, Pratap M, Singh S, Brahmachari M, Banerjee A, Brahmachari S. Surgical site infection among postoperative patients of a tertiary care centre in Central India: A prospective study. Asian J Biomed Pharm Sci. 2023;3:41–44.
  13. Khairy GA. Surgical site infection in a teaching hospital: A prospective study. J Taibah Univ Med Sci. 2011;6(2):114–120.
  14. Giridhar T, Priya PP, Gowtham P. Surgical site infections: A study of incidence, risk factors and antimicrobial sensitivity at RIMS, Kadapa, A.P. J Evol Med Dent Sci. 2015;4(64):11187–11192. doi:10.14260/jemds/2015/1611
  15. Jiji R, Anandan H, Kannan K, Thomas A. Spectrum of surgical site infections in general surgery: Risk factors and antibiotic susceptibility pattern in a tertiary care centre, India. Eur J Pharm Med Res. 2022;9(10):526–531.
  16. Thummar G, Bhavsar S, Chaudhary HK, Chaudhary DM, Shah UV. A study of bacterial pathogens causing surgical site infection and their antimicrobial susceptibility in a tertiary care hospital. Asian J Pharm Clin Res. 2022;15(8):71–74. doi:10.22159/ajpcr.2022.v15i8.45683
  17. Chaudhari MA, Shah SM. A prospective study of antibiotic sensitivity profile of pathogens isolated from surgical site infection at major surgical departments at a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2017;7(2):165–169.
  18. Verma AK. Antimicrobial susceptibility pattern of bacterial isolates from surgical wound infections in a tertiary care hospital in Allahabad, India. Internet J Med Update. 2012;7(1):27–34.
  19. Najam M, Prakash N, Harshavardhan LH, Shrestha KC. Bacterial diversity and antimicrobial resistance in surgical site infections: A challenge to be tackled at the earliest. Indian J Microbiol Res. 2015;2(4):206–209.

Reference

  1. World Health Organization. Global guidelines for the prevention of surgical site infection. Geneva: WHO; 2016.
  2. Centers for Disease Control and Prevention (CDC). National Nosocomial Infections Surveillance (NNIS) System Report, 1992.
  3. Anvikar AR, Deshmukh AB, Karyakarte RP, et al. A one year prospective study of 3,280 surgical wounds. Indian J Med Microbiol. 1999;17(3):129–132.
  4. National Healthcare Safety Network (NHSN) Risk Index. CDC, 2021.
  5. Shanmugam G, Venkatesh B, Perumal M. Bacteriological profile of surgical site infections and their antibiogram in a teaching hospital. J Clin Diagn Res. 2012;6(6):1040–1044.
  6. Patel LP, Panchal SJ. Antibiotic susceptibility pattern of organisms causing surgical site infection at a tertiary care hospital in Gujarat, India. Int J Basic Clin Pharmacol. 2013;2(3): 295–298.
  7. Gomathi S, Srirangaraj S. A study of surgical site infections in a teaching hospital. Int J Curr Microbiol App Sci. 2015;4(10):784–790.
  8. Vyas K, Jain S, Dave M. Surgical site infections and antimicrobial resistance pattern: A study from Western Rajasthan. Int J Res Med Sci. 2016;4(7):2937–2942.
  9. Bastola R, Parajuli P, Neupane A, Paudel A. Surgical site infections: Distribution studies of sample, outcome and antimicrobial susceptibility testing. J Med Microb Diagn. 2017;6:252. doi:10.4172/2161-0703.1000252
  10. Naz R, Hussain SM, Ain Qul. Bacteriological profile of surgical site infections and their antibiotic susceptibility pattern. SSR Inst Int J Life Sci. 2019;5(2):2224–2229.
  11. Budhani D, Kumar S, Sayal P, Singh S. Bacteriological profile and antibiogram of surgical site infection/post-operative wound infection. Int J Med Res Rev. 2016;4(11):1994–1999.
  12. Saxena A, Pratap M, Singh S, Brahmachari M, Banerjee A, Brahmachari S. Surgical site infection among postoperative patients of a tertiary care centre in Central India: A prospective study. Asian J Biomed Pharm Sci. 2023;3:41–44.
  13. Khairy GA. Surgical site infection in a teaching hospital: A prospective study. J Taibah Univ Med Sci. 2011;6(2):114–120.
  14. Giridhar T, Priya PP, Gowtham P. Surgical site infections: A study of incidence, risk factors and antimicrobial sensitivity at RIMS, Kadapa, A.P. J Evol Med Dent Sci. 2015;4(64):11187–11192. doi:10.14260/jemds/2015/1611
  15. Jiji R, Anandan H, Kannan K, Thomas A. Spectrum of surgical site infections in general surgery: Risk factors and antibiotic susceptibility pattern in a tertiary care centre, India. Eur J Pharm Med Res. 2022;9(10):526–531.
  16. Thummar G, Bhavsar S, Chaudhary HK, Chaudhary DM, Shah UV. A study of bacterial pathogens causing surgical site infection and their antimicrobial susceptibility in a tertiary care hospital. Asian J Pharm Clin Res. 2022;15(8):71–74. doi:10.22159/ajpcr.2022.v15i8.45683
  17. Chaudhari MA, Shah SM. A prospective study of antibiotic sensitivity profile of pathogens isolated from surgical site infection at major surgical departments at a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2017;7(2):165–169.
  18. Verma AK. Antimicrobial susceptibility pattern of bacterial isolates from surgical wound infections in a tertiary care hospital in Allahabad, India. Internet J Med Update. 2012;7(1):27–34.
  19. Najam M, Prakash N, Harshavardhan LH, Shrestha KC. Bacterial diversity and antimicrobial resistance in surgical site infections: A challenge to be tackled at the earliest. Indian J Microbiol Res. 2015;2(4):206–209.

Photo
Fathima Juhaina M Abdul Khader
Corresponding author

Pharm D intern, Department of Pharmacy Practice, EGS Pillay College of Pharmacy, Nagapattinam-611002, Tamil Nadu

Photo
Dr. M. Arhoul Rennies
Co-author

Assistant Professor, Department of Pharmacy Practice, EGS Pillay College of Pharmacy, Nagapattinam- 611002, Tamil Nadu

Photo
K. Janani
Co-author

Pharm D intern, Department of Pharmacy Practice, EGS Pillay College of Pharmacy, Nagapattinam-611002, Tamil Nadu

Photo
A. Lakshmikaanthan
Co-author

Pharm D intern, Department of Pharmacy Practice, EGS Pillay College of Pharmacy, Nagapattinam- 611002, Tamil Nadu

Dr. M. Arhoul Rennies, Fathima Juhaina M Abdul Khader, K. Janani, A. Lakshmikaanthan, A Prospective Study on The Bacteriological Profile and Antimicrobial Susceptibility of Surgical Site Infections in A General Surgery Ward at A Tertiary Care Hospital in South India, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 7, 3044-3055. https://doi.org/10.5281/zenodo.16312921

More related articles
A Review of the Role of Oxytocin in Polycystic Ova...
Khushi M. Kongre, Saloni H. Nagpure, Milind J. Umekar, ...
Design, Development And In-Vitro Evaluation Of Par...
Tammanna Donadkar, Reetesh Yadav, Shagun Upadhyay, ...
Prevention Of Obesity - The First And Foremost Str...
J.C. Balachandar, M. Jayachandran, Shiv Swaroop Singh IRS, Saanvi...
A Comprehensive Case Analysis of Takayasu Arteritis: Unraveling the Complexity o...
Konda Siva Krishna, Satheesh S. Gottipati, Juturu Revathi Devi, Nadakuduru Hemanjali, Shaik Musheera...
Recent And Advance Study On Anticancer Drugs ...
Rutuja P. Nirmal , Rutuja Jogdande , Jaya Kamble, Pritam Solakhe , Nilesh Chougule , ...
A Review On HPLC Analytical Method And Validation For Determination Of Sitaglipt...
Kajal Vable, Harshit Prajapati, Chainesh Shah, Umesh Upadhyay , ...
Related Articles
Formulation And Evaluation of a Mimosa Pudica Leaf Extract-Based Transdermal Pat...
Roshani Garkal, Rugvedi Hiwase, Vaishnavi Bhatkar, Pooja Bekate, Dr. Swati Deshmukh, ...
A Review on Advanced Herbal Technology ...
Gavhane Prasad Balasaheb , Dr.Pawan S Avahd , Sanap Tushar Khanderao , Badwar Onkar Satish , ...
A Review on Systematic Study of Digitalies ...
Bhagyashri Randhawan, Atole S. S, Mudgal A. S, Salunke S. S, ...
A Review of the Role of Oxytocin in Polycystic Ovary Syndrome ...
Khushi M. Kongre, Saloni H. Nagpure, Milind J. Umekar, ...
More related articles
A Review of the Role of Oxytocin in Polycystic Ovary Syndrome ...
Khushi M. Kongre, Saloni H. Nagpure, Milind J. Umekar, ...
Prevention Of Obesity - The First And Foremost Strategy For Mankind To Prevent L...
J.C. Balachandar, M. Jayachandran, Shiv Swaroop Singh IRS, Saanvi Agrawal, S. Irshad Ahamed, A. Ayes...
A Review of the Role of Oxytocin in Polycystic Ovary Syndrome ...
Khushi M. Kongre, Saloni H. Nagpure, Milind J. Umekar, ...
Prevention Of Obesity - The First And Foremost Strategy For Mankind To Prevent L...
J.C. Balachandar, M. Jayachandran, Shiv Swaroop Singh IRS, Saanvi Agrawal, S. Irshad Ahamed, A. Ayes...